A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies

Overview of attention for article published in Frontiers in oncology, June 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 13 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 7,437 followers.

New article: A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies https://t.co/dT5jfJCvGT #kidneycancer #oncology https://t.co/ImHrpIt3RE

08 Jul 2022

Reply Repost Favourite

📄 New article: A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies 👨‍⚕️👩‍⚕️ Dennis Gürgen et al Read here 👉 https://t.co/G1WESZUsCK #RCCsm #K

26 Jun 2022

Reply Repost Favourite

New research: A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies: Renal cell carcinoma (RCC) is a kidney cancer with an onset… https://t.co/tL1

22 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.